Birchview Capital as of Dec. 31, 2024
Portfolio Holdings for Birchview Capital
Birchview Capital holds 68 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 31.6 | $39M | 685k | 56.56 | |
| Biodesix (BDSX) | 7.0 | $8.5M | 5.6M | 1.53 | |
| ACADIA Pharmaceuticals (ACAD) | 5.1 | $6.2M | 338k | 18.35 | |
| Aziyo Biologics (ELUT) | 3.7 | $4.6M | 1.2M | 3.74 | |
| Prothena Corp SHS (PRTA) | 3.4 | $4.2M | 305k | 13.85 | |
| Neurocrine Biosciences (NBIX) | 3.4 | $4.1M | 30k | 136.50 | |
| Corcept Therapeutics Incorporated (CORT) | 3.0 | $3.7M | 74k | 50.39 | |
| United Therapeutics Corporation (UTHR) | 2.9 | $3.5M | 10k | 352.84 | |
| Axogen (AXGN) | 2.6 | $3.2M | 197k | 16.48 | |
| Docgo (DCGO) | 2.6 | $3.2M | 764k | 4.24 | |
| Quidel Corporation | 2.5 | $3.0M | 68k | 44.55 | |
| Phreesia (PHR) | 2.4 | $2.9M | 115k | 25.16 | |
| Travere Therapeutics (TVTX) | 2.1 | $2.6M | 148k | 17.42 | |
| Masimo Corporation (MASI) | 2.1 | $2.5M | 15k | 165.30 | |
| Harrow Health (HROW) | 2.0 | $2.4M | 73k | 33.55 | |
| Stoke Therapeutics (STOK) | 1.9 | $2.3M | 210k | 11.03 | |
| Encana Corporation (OVV) | 1.7 | $2.1M | 52k | 40.50 | |
| Castle Biosciences (CSTL) | 1.7 | $2.1M | 78k | 26.65 | |
| Protagonist Therapeutics (PTGX) | 1.5 | $1.9M | 48k | 38.60 | |
| EQT Corporation (EQT) | 1.3 | $1.6M | 35k | 46.11 | |
| Foghorn Therapeutics (FHTX) | 1.2 | $1.5M | 311k | 4.72 | |
| Alkermes SHS (ALKS) | 1.2 | $1.4M | 50k | 28.76 | |
| Treace Med Concepts (TMCI) | 1.0 | $1.2M | 161k | 7.44 | |
| Novocure Ord Shs (NVCR) | 0.8 | $924k | 31k | 29.80 | |
| 10x Genomics Cl A Com (TXG) | 0.6 | $718k | 50k | 14.36 | |
| Ultragenyx Pharmaceutical (RARE) | 0.5 | $673k | 16k | 42.07 | |
| Xencor (XNCR) | 0.5 | $598k | 26k | 22.98 | |
| Kiniksa Pharmaceuticals | 0.5 | $593k | 30k | 19.78 | |
| Kalvista Pharmaceuticals (KALV) | 0.5 | $568k | 67k | 8.47 | |
| Alphatec Holdings (ATEC) | 0.4 | $532k | 58k | 9.18 | |
| Candel Therapeutics (CADL) | 0.4 | $521k | 60k | 8.68 | |
| Wave Life Sciences SHS (WVE) | 0.4 | $495k | 40k | 12.37 | |
| Inhibrx Biosciences (INBX) | 0.4 | $495k | 32k | 15.40 | |
| Halozyme Therapeutics (HALO) | 0.4 | $478k | 10k | 47.81 | |
| Cytokinetics (CYTK) | 0.4 | $470k | 10k | 47.04 | |
| Apellis Pharmaceuticals (APLS) | 0.4 | $447k | 14k | 31.91 | |
| Sarepta Therapeutics (SRPT) | 0.3 | $426k | 3.5k | 121.59 | |
| Outset Med | 0.3 | $409k | 369k | 1.11 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $392k | 10k | 39.20 | |
| Accelr8 Technology | 0.3 | $390k | 325k | 1.20 | |
| Tela Bio (TELA) | 0.3 | $378k | 125k | 3.02 | |
| Springworks Therapeutics (SWTX) | 0.3 | $361k | 10k | 36.13 | |
| Uniqure Nv SHS (QURE) | 0.3 | $353k | 20k | 17.66 | |
| Pulmonx Corp (LUNG) | 0.3 | $346k | 51k | 6.79 | |
| Scholar Rock Hldg Corp (SRRK) | 0.3 | $346k | 8.0k | 43.22 | |
| Axsome Therapeutics (AXSM) | 0.3 | $338k | 4.0k | 84.61 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $301k | 40k | 7.52 | |
| Atara Biotherapeutics Com New (ATRA) | 0.2 | $293k | 22k | 13.31 | |
| Arvinas Ord (ARVN) | 0.2 | $288k | 15k | 19.17 | |
| Karyopharm Therapeutics | 0.2 | $284k | 420k | 0.68 | |
| Biohaven Pharmaceutical Holding | 0.2 | $275k | 7.4k | 37.35 | |
| Amicus Therapeutics (FOLD) | 0.2 | $264k | 28k | 9.42 | |
| Cullinan Oncology (CGEM) | 0.2 | $244k | 20k | 12.18 | |
| Keros Therapeutics (KROS) | 0.2 | $238k | 15k | 15.83 | |
| Blueprint Medicines (BPMC) | 0.2 | $236k | 2.7k | 87.22 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.2 | $217k | 4.0k | 54.15 | |
| Zenas Biopharma (ZBIO) | 0.1 | $135k | 17k | 8.19 | |
| Direxion Daily Pharmaceutical & Medical Bull 3x Sh Dly Tech Bull 3x (TECL) | 0.1 | $128k | 18k | 7.10 | |
| Gossamer Bio (GOSS) | 0.1 | $125k | 138k | 0.90 | |
| Inflarx Nv (IFRX) | 0.1 | $124k | 50k | 2.47 | |
| Liquidia Technologies (LQDA) | 0.1 | $118k | 10k | 11.76 | |
| Coherus Biosciences (CHRS) | 0.1 | $113k | 82k | 1.38 | |
| Neuropace (NPCE) | 0.1 | $112k | 10k | 11.19 | |
| Alumis (ALMS) | 0.1 | $79k | 10k | 7.86 | |
| Ventyx Biosciences (VTYX) | 0.1 | $63k | 29k | 2.19 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.0 | $52k | 17k | 3.03 | |
| 2seventy Bio | 0.0 | $47k | 16k | 2.94 | |
| Cero Therapeutics Holdings Class A Com | 0.0 | $778.320000 | 13k | 0.06 |